Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSIX: Stem Cells for Sjögren's Xerostomia
NCT06805448Phase 2Recruiting
- Sponsor
- Rigshospitalet
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose derived mesenchymal stromal cells in Sjögren's syndrome, sponsored by Rigshospitalet. Started Jan 2025; status: recruiting.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT06805448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06805448.